Prosetta Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Prosetta Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10916
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Prosetta Biosciences Inc (Prosetta Biosciences), formerly Prosetta Antiviral Inc is a developer of novel small-molecule antiviral drugs based on research on the cell-free protein synthesizing systems. The company uses cell-free protein synthesizing systems to identify new protein-protein interactions that results in the discovery of chemical classes of small molecule inhibitors for all viral families. It also produces potent compounds that are active against viral strains. Prosetta Biosciences performs programs in the therapeutic areas of pan respiratory, oncology, amyotrophic lateral schlerosis, Parkinson’s disease, HIV and rabies. The company commercializes its products through research and drug development partnerships with pharmaceutical and biotech companies. Prosetta Biosciences is headquartered in San Francisco, California, the US.

Prosetta Biosciences Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Prosetta Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Prosetta Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Prosetta Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Prosetta Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Prosetta Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Prosetta Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Prosetta Bioconformatics Raises US$2.03 Million In Venture Financing 10
Partnerships 11
Prosetta Biosciences Enters into Agreement with Takeda Pharma 11
Prosetta Enters Into Co-Development Agreement With Bristol-Myers Squibb For Antiviral Drugs 12
Equity Offering 13
Prosetta Biosciences Raises USD31 Million in Series D Private Placement 13
Prosetta Biosciences Inc – Key Competitors 14
Prosetta Biosciences Inc – Key Employees 15
Prosetta Biosciences Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Prosetta Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts 2
Prosetta Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Prosetta Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Prosetta Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Prosetta Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Prosetta Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Prosetta Bioconformatics Raises US$2.03 Million In Venture Financing 10
Prosetta Biosciences Enters into Agreement with Takeda Pharma 11
Prosetta Enters Into Co-Development Agreement With Bristol-Myers Squibb For Antiviral Drugs 12
Prosetta Biosciences Raises USD31 Million in Series D Private Placement 13
Prosetta Biosciences Inc, Key Competitors 14
Prosetta Biosciences Inc, Key Employees 15

List of Figures
Prosetta Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Prosetta Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Prosetta Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Prosetta Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Prosetta Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Prosetta Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Prosetta Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Prosetta Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Prosetta Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • JPT Peptide Technologies GmbH(製薬・医療分野):企業M&A動向
    Summary JPT Peptide Technologies GmbH (JPT) is a biotechnology company. The company develops and provides peptide based products and custom services to research and development companies. Its product segments include immune tools, custom peptide and arrays, and proteomics and enzyme profiling. JPT p …
  • Avi Tech Electronics Ltd. (CT1):企業概要、財務及び戦略的SWOT分析
    Summary Avi Tech Electronics Ltd. (Avi-Tech) is a technical service provider. The company provides a range of services and solutions for clients in the semiconductor, electronics and life sciences industries. It offers burn-in services, burn-in boards and board manufacturing services, engineering se …
  • CareGroup Inc:企業の戦略的SWOT分析
    CareGroup Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Singapore Technologies Electronics Ltd.(航空・防衛):企業概要、SWOT分析
    Summary Strategic Defence Intelligence's "Singapore Technologies Electronics Ltd.: Aerospace and Defense - Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, …
  • Hovnanian Enterprises, Inc.:企業の戦略・SWOT・財務情報
    Hovnanian Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hovnanian Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Flexera Software LLC:企業の戦略的SWOT分析
    Flexera Software LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Northern Trust Corporation:企業の戦略・SWOT・財務情報
    Northern Trust Corporation - Strategy, SWOT and Corporate Finance Report Summary Northern Trust Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Smartcool Systems, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Smartcool Systems, Inc. Mergers …
  • Finsbury Food Group PLC (FIF):企業概要、財務及び戦略的SWOT分析
    Summary Finsbury Food Group PLC (Finsbury) is a food product manufacturer. The company manufactures and markets a wide range of bakery products. Its products include party cakes, festival cakes, premium cakes, kids cakes, triple-layer cakes, loaf cakes, crumble cakes, tiffin, mini and giant rolls, r …
  • EOS GmbH Electro Optical Systems:企業の戦略・SWOT・財務分析
    SummaryEOS GmbH Electro Optical Systems - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the com …
  • Itamar Medical Ltd (ITMR):企業のM&A・提携動向(医療機器分野)
    Summary Itamar Medical Ltd (Itamar Medical) is a medical technology company which offers bio-medical technology products. It develops, markets and distributes diagnostic medical devices. The company’s products include EndoPAT, a medical device for the diagnosis of endothelial dysfunction; and WatchP …
  • PetroChina Company Limited (857):企業のM&A・提携動向(エネルギー分野)
    Summary PetroChina Company Limited (PetroChina) is an oil and gas company that explores for, develops and produces crude oil and natural gas; refines crude oil and petroleum products; and produces and sells basic and derivative chemical products and other chemical products. It also markets and trade …
  • The Sherwin-Williams Company:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' The Sherwin-Williams Company Me …
  • Sunoco, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Sunoco, Inc. Mergers and Acquis …
  • Phoenix Brands LLC:企業の戦略・SWOT・財務分析
    SummaryPhoenix Brands LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Find …
  • ViewRay, Inc.:企業のM&A・提携動向(医療機器分野)
    Summary ViewRay, Inc. (ViewRay) is a medical device company that develops advanced radiation therapy technology for the treatment of cancer. The company’s ViewRay system provides continuous soft-tissue imaging during treatment by using MRI-guided radiotherapy. Its ViewRay system enables clinicians t …
  • OsteoVantage Inc:製品パイプライン分析
    Summary OsteoVantage Inc (OsteoVantage) is a medical device company that develops osteogenic spinal instrumentation technology used in spinal fusion procedures. The company’s INDOS system is an osteogenic spinal instrumentation for use in lumbar spinal fusion procedures. It also offers osteomodulati …
  • Lixte Biotechnology Holdings Inc (LIXT):製薬・医療:M&Aディール及び事業提携情報
    Summary Lixte Biotechnology Holdings Inc (Lixte) is a clinical stage pharmaceutical company, which focuses on the discovery of novel drugs for the treatment of cancer and non-malignant diseases. It develops comprises two classes of drugs, namely, protein phosphatase inhibitors (PTase-i) designated a …
  • GrafTech International Ltd.:企業の戦略・SWOT・財務分析
    SummaryGrafTech International Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • TCFC Finance Limited (532284):企業財務及び戦略的SWOT分析
    Summary TCFC Finance Limited (TCFC Finance) is a non-banking finance company that offers investment service. The company’s activities in the business of finance and investments and trading include equity shares, mutual funds and securities, among others. It is an investment company that operates its …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆